Lyft (LYFT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. How do you find the right combination ...

CVNA, SFM, and URBN earn Zacks' top rank as CPI surprise boosts sentiment; EPS estimates surge across retail names.

Rithm (RITM) concluded the recent trading session at $11.29, signifying a -1.4% move from its prior day's close.

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. How do you find the ...

The latest trading day saw Lyft (LYFT) settling at $14.78, representing a -4.27% change from its previous close.

AppLovin Corp. has delivered a stunning 50% surge over the past three months, significantly outperforming the industry 's 21% ...

Pacific Biosciences of California (PACB) ended the recent trading session at $1.18, demonstrating a +1.72% change from the ...